This announcement informs that Wanbangde Pharmaceutical Holdings Group Co., Ltd. has received a negative audit opinion on its internal controls for the 2025 fiscal year, leading to other risk warnings on its stock. The company is taking measures to address these issues, including forming a special task force and conducting compliance training. The company assures that its operations are normal and will continue to disclose relevant updates.
Summary generated by AI · Always verify with source document
Securities Code: 002082
Securities Abbreviation: ST Wanbang
Announcement Number: 2026-043
Wanbangde Pharmaceutical Holdings Group Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.